<img height="1" width="1" style="display:none" src="https://www.facebook.com/tr?id=875423625897521&amp;ev=PageView&amp;noscript=1">

Sensing Savvy

Kidney Care News to Know From March

Posted by Deborah Brouwer-Maier RN, CNN on Mar 29, 2017 6:30:00 AM

kidney care newsFresenius, Cigna Partner for Collaborative Care

The national program aims to lower the cost of care for patients with end stage renal disease undergoing dialysis while also improving quality. The program will be part of Cigna’s Collaborative Care, a value-based model that uses incentives to engage healthcare providers.

Fresenius Medical Care North America will still be paid for the dialysis services it provides to Cigna patients and Fresenius Health Partners will assume separate responsibility to manage medical costs and improve patient outcomes.

Source: Nephrology News & Issues

Undocumented Immigrants with ESRD Face Poor Access to Health Care

About 6,480 undocumented immigrants in the United States have ESRD. These immigrants who rely on emergency room treatment and hemodialysis report feeling substantial physical and psychological distress. This could be because undocumented immigrants aren’t eligible to receive standard hemodialysis and present to the emergency room very ill in hopes of receiving treatment.

Source: Renal & Urology News

DaVita’s Revenues Take Hit from 3rd-Party Payment Policy Changes

The company reported that losses from the third-party payer policy changes for dialysis patients enrolled in Affordable Care Act health plans will take a major bite out of the company’s bottom line for 2017. The losses likely will be the largest drop in one-year revenue in the company’s 17-year history.

Source: Nephrology News & Issues

Red Blood Cell Size Linked to Death in Chronic Kidney Disease Patients

Higher mean corpuscular volume (MCV) in stage three to five chronic kidney disease patients is associated with higher risk of death from heart problems, infections and other causes.

Source: Renal & Urology News

Fresenius Medical Care Buys Majority Stake in Australia’s Cura Group

Cura Group operates 19 private day hospitals in Australia and provides outpatient ambulant services. After the deal is finalized, Fresenius will have 40 outpatient facilities in Australia.

Source: Nephrology News & Issues

Cardia Function eBook

Topics: kidney care